REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 2 filers reported holding REPARE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $618,919 | +6.7% | 51,235 | -6.6% | 0.00% | – |
| Q2 2023 | $580,228 | +7.7% | 54,842 | +0.1% | 0.00% | – |
| Q1 2023 | $538,857 | +68719.5% | 54,762 | +3.0% | 0.00% | – |
| Q4 2022 | $783 | -99.5% | 53,185 | +309.8% | 0.00% | – |
| Q3 2022 | $157,000 | -73.2% | 12,979 | -69.0% | 0.00% | – |
| Q2 2022 | $585,000 | -17.5% | 41,846 | -16.0% | 0.00% | – |
| Q1 2022 | $709,000 | -34.7% | 49,811 | -3.2% | 0.00% | – |
| Q4 2021 | $1,085,000 | +5.3% | 51,436 | +31.1% | 0.00% | – |
| Q3 2021 | $1,030,000 | – | 39,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $28,001,631 | 33.22% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $23,727,089 | 11.64% |
| CHI Advisors LLC | 2,998,734 | $31,726,606 | 9.63% |
| MPM BioImpact LLC | 1,639,849 | $17,349,602 | 3.49% |
| BVF INC/IL | 8,291,988 | $87,729,233 | 2.44% |
| Deep Track Capital, LP | 2,727,606 | $28,858,071 | 1.34% |
| Redmile Group, LLC | 2,428,335 | $25,691,784 | 0.99% |
| HighVista Strategies LLC | 165,173 | $1,747,530 | 0.80% |
| Orbimed Advisors | 3,322,488 | $35,151,923 | 0.64% |
| DIFESA CAPITAL MANAGEMENT, LP | 15,416 | $163,101 | 0.43% |